LGND has had a pipeline of Serms in development it seems like forever. Do you or anybody else have an opinion on when, if ever, LGND will become profitable with + earnings/share?
LGND was one of my earliest biotech "investments"---I visited the company in the the mid '90s. Lucky, so far, I guess, the investment was relatively modest.
Market Data 
Markets 
AI
